Neuroendocrine Cancer | Tumor

CURE’s neuroendocrine cancer page features the latest cancer news and updates on neuroendocrine cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in neuroendocrine cancer.

FDA Approves Cabometyx for Some Neuroendocrine Tumors

March 26th 2025, 1:44pm

Article

The FDA has approved Cabometyx for some patients 12 years old and older with pancreatic neuroendocrine tumors and extra-pancreatic neuroendocrine tumors.

177Lu-edotreotide May Delay Progression in Neuroendocrine Tumor Subset

March 7th 2025, 10:00pm

Article

177Lu-edotreotide shows potential to extend progression-free survival in patients with grade 1 or 2 somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors.

ITM-11 Meets Phase 3 Trial Primary End Point of PFS in GEP-NETs

February 2nd 2025, 7:00pm

Article

Topline results from the COMPETE trial showed that ITM-11 met the study’s primary end point of PFS in inoperable, progressive grade 1 or grade 2 GEP-NETs.

FDA Accepts sNDA for Welireg in Advanced Pheochromocytoma and Paraganglioma

January 29th 2025, 2:00pm

Article

The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic pheochromocytoma and paraganglioma.

A Holiday Poem: Who Says Cancer Doesn’t Rhyme?

December 18th 2024, 6:00pm

Article

The holiday season is here, so here’s a festive poem to remind us that cancer should not control us during this time.

The Challenge of Finding Out What My Cancer Type Was

November 30th 2024, 7:00pm

Article

Before I underwent surgery to remove tumors on several organs, I was told it was the only way to determine what cancer I had.

In Cancer, the Whole Is Greater Than the Sum of Its Parts

October 22nd 2024, 5:00pm

Article

In addition to receiving my traditional cancer treatments, I also opt for integrative medicines, which have helped my mental health.

You Can’t Spell Patient Without AI

October 8th 2024, 5:00pm

Article

Cancer is complicated, especially with multiple diagnoses, oncologists, tests and integrative treatments, but AI can be a helpful tool.

FDA Accepts Supplemental New Drug Application for Cabometyx in Pancreatic NETs

August 7th 2024, 7:00pm

Article

The FDA will review an application for Cabometyx as a potential treatment for pancreatic neuroendocrine tumors after findings from a phase 3 trial.

Feeling Imposter Syndrome in the Cancer Community

August 6th 2024, 5:00pm

Article

Understanding how I fit in matters to me but figuring out my identity in the cancer space is not always easy.